// App-Quantinova.ai

379 : Heterogeneity of circulating tumor cells based on asialoglycoprotein receptor 1 (ASGPR1) expression in hepatocellular carcinoma as prognostic tool

Researchers

Presenter

  • Amparo Roa Colomo

Principal Investigators

  • Mara ngeles Lpez Garrido

  • Mercedes Gonzalez Sanchez

  • Flor Nogueras Sanchez

  • Mara Dolores Espinosa Aguilar

  • Ana Gila Medina

  • Javier Salmeron

  • Angela Rojas

  • Manuel Romero-Gomez

  • Jordi Muntane

  • Pilar Molina-Vallejo

  • Jose A. Lorente

  • Mara Jos Serrano

  • M. Carmen Garrido-Navas

Medical Centers

  • Clinical Medicine and Public Health Doctoral Program. University of Granada. 18016, Granada, Spain

  • Gastroenterology and Hepatology Department. Virgen De Las Nieves, University Hospital, Granada, Spain

  • Gastroenterology and Hepatology Department. Virgen De Las Nieves, University Hospital, Granada, Spain

  • Gastroenterology and Hepatology Department. Virgen De Las Nieves, University Hospital, Granada, Spain

  • Medicine Department, Medicine School, University of Granada, 18016, Granada, Spain

  • Traslational and Clinical Research Laboratory ‐ Liver and Digestive Diseases ‐ Ciberehd, Institute of Biomedicine of Seville, Virgen Del Rocío University Hospital/Csic/University of Seville, Seville 41013, Spain

  • Hepatology, Virgen Del Rocio University Hospital,

  • Seliver Group. Instituto De Biomedicina De Sevilla

  • , Hospital Universitario Virgen Del Rocío/Csic/Universidad De Sevilla

  • Departament of Surgery, Hospital Universitario Virgen Del Rocío, Sevilla, España. 4. Centro De Investigación Biomédica En Red De Enfermedades Hepáticas y Digestivas, Instituto De Salud Carlos III

  • Genyo‐Centro Pfizer‐ Universidad De Granada‐Junta De Andalucía De Genómica e Investigación Oncológica, 18016, Granada, Spain,

  • Medicine Department, Medicine School, University of Granada, 18016, Granada, Spain

  • Ugc of Integral Oncology, Complejo Hospitalario De Granada, IBS Granada, Instituto De Investigación Biosanitaria De Granada, 18012, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Liver cancer

  • Cirrhosis

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved